资讯

The business mogul, designer and activist will accept the honor in Beverly Hills, Calif., on Sept. 18. The gala, fronted by ...
Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...
GILD jumps 27.2% in six months as FDA nod for twice-yearly HIV drug Yeztugo boosts its HIV franchise and growth outlook.
Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.
The Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers during the week and a look ...
A new twice-yearly antiviral injection that can prevent HIV is likely to be approved soon in Australia. Making it affordable ...
On June 27th, celebrity and cultural advocate Miss Lawrence returned to Atlanta with Plated Purpose, an immersive dining ...
Baltimore's beloved live music tradition, Jazzy Summer Nights is well into its 25th and final season. This farewell season, ...
Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...
在人类与疾病的持续抗争中,科学家以无畏的勇气和执着的精神,向未知挑战,不断推动药物革新,为人类健康带来更多新的希望。 “命运不是判决书” 抗病毒药物改写历史 ...